Published in Structure on July 15, 2000
Structural basis for Fe-S cluster assembly and tRNA thiolation mediated by IscS protein-protein interactions. PLoS Biol (2010) 2.60
Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nat Struct Mol Biol (2009) 2.08
Yeast frataxin solution structure, iron binding, and ferrochelatase interaction. Biochemistry (2004) 1.80
Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal (2008) 1.73
The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J Neurol (2009) 1.68
Monomeric yeast frataxin is an iron-binding protein. Biochemistry (2006) 1.67
Iron-binding activity in yeast frataxin entails a trade off with stability in the alpha1/beta1 acidic ridge region. Biochem J (2010) 1.66
The structure and function of frataxin. Crit Rev Biochem Mol Biol (2006) 1.59
Structural bases for the interaction of frataxin with the central components of iron-sulphur cluster assembly. Nat Commun (2010) 1.56
Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis (2006) 1.34
Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid Redox Signal (2010) 1.27
Acidic residues of yeast frataxin have an essential role in Fe-S cluster assembly. EMBO Rep (2006) 1.24
Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assembly. J Biol Chem (2010) 1.23
Friedreich ataxia: from GAA triplet-repeat expansion to frataxin deficiency. Am J Hum Genet (2001) 1.06
Conformational stability of human frataxin and effect of Friedreich's ataxia-related mutations on protein folding. Biochem J (2006) 1.05
Structure-function analysis of Friedreich's ataxia mutants reveals determinants of frataxin binding and activation of the Fe-S assembly complex. Biochemistry (2011) 1.04
The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia. PLoS One (2009) 1.02
Human frataxin: iron and ferrochelatase binding surface. Chem Commun (Camb) (2007) 1.00
N-terminal iron-mediated self-cleavage of human frataxin: regulation of iron binding and complex formation with target proteins. J Biol Inorg Chem (2007) 0.98
Friedreich's ataxia variants I154F and W155R diminish frataxin-based activation of the iron-sulfur cluster assembly complex. Biochemistry (2011) 0.97
Ferredoxin competes with bacterial frataxin in binding to the desulfurase IscS. J Biol Chem (2013) 0.96
Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal (2013) 0.94
Mapping iron binding sites on human frataxin: implications for cluster assembly on the ISU Fe-S cluster scaffold protein. J Biol Inorg Chem (2008) 0.92
Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation. Front Pharmacol (2014) 0.91
The N-terminus of mature human frataxin is intrinsically unfolded. FEBS J (2009) 0.90
Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene. J Neurol (2012) 0.86
Tangled web of interactions among proteins involved in iron-sulfur cluster assembly as unraveled by NMR, SAXS, chemical crosslinking, and functional studies. Biochim Biophys Acta (2014) 0.83
Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia. Br J Pharmacol (2014) 0.83
NMR assignments of a stable processing intermediate of human frataxin. Biomol NMR Assign (2010) 0.80
Selective observation of the disordered import signal of a globular protein by in-cell NMR: the example of frataxins. Protein Sci (2015) 0.79
Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells. Neurobiol Dis (2014) 0.78
His86 from the N-terminus of frataxin coordinates iron and is required for Fe-S cluster synthesis. Biochemistry (2013) 0.78
Iron chaperones for mitochondrial Fe-S cluster biosynthesis and ferritin iron storage. Curr Opin Chem Biol (2011) 0.78
Protein stability and dynamics modulation: the case of human frataxin. PLoS One (2012) 0.77
Crystal Structure of Bacillus subtilis Cysteine Desulfurase SufS and Its Dynamic Interaction with Frataxin and Scaffold Protein SufU. PLoS One (2016) 0.76
Analyzing the Effects of a G137V Mutation in the FXN Gene. Front Mol Neurosci (2015) 0.76
Probing the kinetic stabilities of Friedreich's ataxia clinical variants using a solid phase GroEL chaperonin capture platform. Biomolecules (2014) 0.75
Frataxin Is Localized to Both the Chloroplast and Mitochondrion and Is Involved in Chloroplast Fe-S Protein Function in Arabidopsis. PLoS One (2015) 0.75
Human Frataxin Folds Via an Intermediate State. Role of the C-Terminal Region. Sci Rep (2016) 0.75
The role of the N-terminal tail for the oligomerization, folding and stability of human frataxin. FEBS Open Bio (2013) 0.75
Structural characterization of metal binding to a cold-adapted frataxin. J Biol Inorg Chem (2015) 0.75
SH3--an abundant protein domain in search of a function. FEBS Lett (1992) 12.98
Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science (1995) 6.67
A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci U S A (2000) 4.88
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 4.80
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Attempt at deriving a formula for setting general practitioner fundholding budgets. BMJ (1994) 4.19
Allocating resources to health authorities: results and policy implications of small area analysis of use of inpatient services. BMJ (1994) 4.17
SMN tudor domain structure and its interaction with the Sm proteins. Nat Struct Biol (2001) 4.03
The PH domain: a common piece in the structural patchwork of signalling proteins. Trends Biochem Sci (1993) 3.89
Allocating resources to health authorities: development of method for small area analysis of use of inpatient services. BMJ (1994) 3.88
Systematic isolation of transducing phages for Myxococcus xanthus. Virology (1978) 3.76
Injuries in Rugby Union football. Br Med J (1979) 3.65
The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends Biochem Sci (1996) 3.55
The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet (2001) 3.01
Structure of the dsRNA binding domain of E. coli RNase III. EMBO J (1995) 3.00
Immunoglobulin-like modules from titin I-band: extensible components of muscle elasticity. Structure (1996) 2.97
The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J (1995) 2.93
Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell (1996) 2.66
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis (2000) 2.57
Identification and preliminary characterization of a protein motif related to the zinc finger. Proc Natl Acad Sci U S A (1993) 2.55
Three-dimensional structure and stability of the KH domain: molecular insights into the fragile X syndrome. Cell (1996) 2.50
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 2.50
The phototrophic bacterium Rhodopseudomonas capsulata sp108 encodes an indigenous class A beta-lactamase. Biochem J (1989) 2.44
Maternal ginseng use associated with neonatal androgenization. JAMA (1990) 2.43
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ Res (2000) 2.39
Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect Immun (1999) 2.31
A regular pattern of two types of 100-residue motif in the sequence of titin. Nature (1990) 2.29
Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. Arch Dis Child (2002) 2.28
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity (1995) 2.19
An in vitro study of dural lesions produced by 25-gauge Quincke and Whitacre needles evaluated by scanning electron microscopy. Reg Anesth Pain Med (2001) 2.18
The Arthritis and Rheumatism Council's National Repository of Family Material: pedigrees from the first 100 rheumatoid arthritis families containing affected sibling pairs. Br J Rheumatol (1994) 2.14
The giant protein titin. Emerging roles in physiology and pathophysiology. Circ Res (1997) 2.14
Towards a molecular understanding of the elasticity of titin. J Mol Biol (1996) 2.12
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A (1991) 2.12
Transportation of prion protein across the intestinal mucosa of scrapie-susceptible and scrapie-resistant sheep. J Pathol (2006) 2.10
A helical arch allowing single-stranded DNA to thread through T5 5'-exonuclease. Nature (1996) 2.07
Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. BMJ (1992) 2.03
A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate. EMBO J (1998) 2.01
In the physician's office: an interview with W. Ray Burns. Am Pharm (1989) 1.98
The complete primary structure of human nebulin and its correlation to muscle structure. J Mol Biol (1995) 1.98
Methods for diagnosing onychomycosis: a comparative study and review of the literature. Arch Dermatol (2000) 1.97
Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition. J Bacteriol (1999) 1.95
The solution structure of human epidermal growth factor. Nature (1987) 1.94
Nature of PEVK-titin elasticity in skeletal muscle. Proc Natl Acad Sci U S A (1998) 1.94
The folding and stability of titin immunoglobulin-like modules, with implications for the mechanism of elasticity. Biophys J (1995) 1.93
An evaluated programme of rheumatology training for general practitioners. Br J Rheumatol (1986) 1.88
Evidence that nebulin is a protein-ruler in muscle thin filaments. FEBS Lett (1991) 1.87
Use of simple analgesics in rheumatoid arthritis. Ann Rheum Dis (1985) 1.84
Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis. J Rheumatol (1992) 1.83
Qualitative and quantitative analysis of the learning curve of a simulated surgical task on the da Vinci system. Surg Endosc (2004) 1.82
Quantitative measurement of short-range chemical bonding forces. Science (2001) 1.81
The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg (1985) 1.78
Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells. Genes Dev (1993) 1.78
The NH2 terminus of titin spans the Z-disc: its interaction with a novel 19-kD ligand (T-cap) is required for sarcomeric integrity. J Cell Biol (1998) 1.78
Controlled comparison of short-wave diathermy treatment with osteopathic treatment in non-specific low back pain. Lancet (1985) 1.74
Zinc finger-DNA recognition: analysis of base specificity by site-directed mutagenesis. Nucleic Acids Res (1992) 1.74
A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated respiratory tract infection in primary care. Br J Gen Pract (2001) 1.73
Effects of agent strain and host genotype on PrP accumulation in the brain of sheep naturally and experimentally affected with scrapie. J Comp Pathol (2002) 1.73
Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J Virol (1989) 1.72
Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children. Cochrane Database Syst Rev (2003) 1.72
Dexterity enhancement with robotic surgery. Surg Endosc (2004) 1.71
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys (2007) 1.70
Tissue-specific expression and alpha-actinin binding properties of the Z-disc titin: implications for the nature of vertebrate Z-discs. J Mol Biol (1997) 1.70
Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet (2001) 1.68
Closure of rhomboid skin defects: the flaps of Limberg and Dufourmentel. Br J Plast Surg (1972) 1.68
Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract (2007) 1.67
Outpatient lumbar epidural corticosteroid injection in the management of sciatica. Br J Rheumatol (1988) 1.67
Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis (1975) 1.67
Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest (1993) 1.65
Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci U S A (1992) 1.65
Allopurinol treatment and its effect on renal function in gout: a controlled study. Ann Rheum Dis (1982) 1.65
Quinidine elimination in patients with congestive heart failure or poor renal function. N Engl J Med (1974) 1.63
Role of serotonin in memory impairment. Ann Med (2000) 1.62
The diagnosis of Poncet's disease. Br J Rheumatol (1993) 1.62
High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapy. Am J Transplant (2011) 1.60
Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol (2001) 1.60
Thoracoscopic repair of instrumental perforation of the oesophagus: first report. Ir J Med Sci (2002) 1.59
Homology between two EBV early genes and HSV ribonucleotide reductase and 38K genes. Nucleic Acids Res (1984) 1.57
A structural approach to understanding the iron-binding properties of phylogenetically different frataxins. Hum Mol Genet (2002) 1.57
Subclinical liver disease in systemic lupus erythematosus. J Rheumatol (1982) 1.57
The three-dimensional structure of the HRDC domain and implications for the Werner and Bloom syndrome proteins. Structure (1999) 1.57
Inflammatory myopathy causing pharyngeal dysphagia: a new entity. Ann Otol Rhinol Laryngol (1996) 1.54
The solution structure of the first KH domain of FMR1, the protein responsible for the fragile X syndrome. Nat Struct Biol (1997) 1.52
Letter: Localized hypertrophic osteoarthropathy with abdominal aortic prosthesis and infection. Ann Intern Med (1974) 1.51
The N-terminal end of nebulin interacts with tropomodulin at the pointed ends of the thin filaments. J Biol Chem (2001) 1.51
Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2. J Biol Chem (1998) 1.51
The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A. Clin Auton Res (2002) 1.51
The benefits of stereoscopic vision in robotic-assisted performance on bench models. Surg Endosc (2004) 1.51
The crystal structure of an intact human Max-DNA complex: new insights into mechanisms of transcriptional control. Structure (1997) 1.51
High-affinity RNA ligands to Escherichia coli ribosomes and ribosomal protein S1: comparison of natural and unnatural binding sites. Biochemistry (1995) 1.50
Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable? BJU Int (2003) 1.50
DNA-binding domain ancestry. Nature (1989) 1.49
The structure of melittin. A 1H-NMR study in methanol. Eur J Biochem (1988) 1.49